SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alice Morassi, Domenico Bianco, Ed Park, Reid K. Nakamura, George A. White, Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia, Journal of Veterinary Emergency and Critical Care, 2016, 26, 2
  2. 2
    Leah A. Cohn, Small Animal Critical Care Medicine, 2015,

    CrossRef

  3. 3
    L.L. Caviezel, K. Raj, U. Giger, Comparison of 4 Direct Coombs' Test Methods with Polyclonal Antiglobulins in Anemic and Nonanemic Dogs for In-Clinic or Laboratory Use, Journal of Veterinary Internal Medicine, 2014, 28, 2
  4. 4
    V. K. Yau, D. Bianco, Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent, Journal of Small Animal Practice, 2014, 55, 6
  5. 5
    J.W. Swann, B.J. Skelly, Systematic Review of Evidence Relating to the Treatment of Immune-Mediated Hemolytic Anemia in Dogs, Journal of Veterinary Internal Medicine, 2013, 27, 1
  6. 6
    Geert Paes, Dominique Paepe, Evelyne Meyer, Annemarie T Kristensen, Luc Duchateau, Miguel Campos, Sylvie Daminet, The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia, Acta Veterinaria Scandinavica, 2013, 55, 1, 74

    CrossRef

  7. 7
    Philip J. Bergman, Withrow and MacEwen's Small Animal Clinical Oncology, 2013,

    CrossRef

  8. 8
    Emmeline Tan, Dorothee Bienzle, Patricia Shewen, Stephen Kruth, Darren Wood, Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia, Veterinary Clinical Pathology, 2012, 41, 1
  9. 9
    Reid K. Nakamura, Emily Tompkins, Domenico Bianco, Therapeutic options for immune-mediated thrombocytopenia, Journal of Veterinary Emergency and Critical Care, 2012, 22, 1
  10. 10
    Christine J. Piek, Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research, Veterinary Quarterly, 2011, 31, 3, 129

    CrossRef

  11. You have free access to this content11
    J. W. Swann, B. J. Skelly, Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs, Journal of Small Animal Practice, 2011, 52, 7
  12. You have free access to this content12
    N. T. Whitley, M. J. Day, Immunomodulatory drugs and their application to the management of canine immune-mediated disease, Journal of Small Animal Practice, 2011, 52, 2
  13. You have free access to this content13
    S. Tasker, J. K. Murray, T. G. Knowles, M. J. Day, Coombs’, haemoplasma and retrovirus testing in feline anaemia, Journal of Small Animal Practice, 2010, 51, 4
  14. 14
    Elizabeth L. Breuhl, George Moore, Marjory B. Brooks, J. Catharine Scott-Moncrieff, A Prospective Study of Unfractionated Heparin Therapy in Dogs With Primary Immune-Mediated Hemolytic Anemia, Journal of the American Animal Hospital Association, 2009, 45, 3, 125

    CrossRef

  15. 15
    Domenico Bianco, Robert M. Hardy, Treatment of Evans’ Syndrome With Human Intravenous Immunoglobulin and Leflunomide in a Diabetic Dog, Journal of the American Animal Hospital Association, 2009, 45, 3, 147

    CrossRef

  16. 16
    Leah A. Cohn, Small Animal Critical Care Medicine, 2009,

    CrossRef

  17. 17
    Dina A. Andrews, Handbook of Small Animal Practice, 2008,

    CrossRef

  18. 18
    Anne C. Avery, Paul R. Avery, Determining the Significance of Persistent Lymphocytosis, Veterinary Clinics of North America: Small Animal Practice, 2007, 37, 2, 267

    CrossRef

  19. 19
    Mark Mathes, Michael Jordan, Steven Dow, Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs, Experimental Hematology, 2006, 34, 10, 1393

    CrossRef

  20. 20
    Sheila McCullough, Immune-mediated hemolytic anemia: understanding the nemesis, Veterinary Clinics of North America: Small Animal Practice, 2003, 33, 6, 1295

    CrossRef

  21. 21
    Veronica Salazar, Neoplastic disease,